MMF Versus CYC in the Induction Therapy of Pediatric Active Proliferative LN

NCT05495893 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

224

Enrollment

OTHER

Sponsor class

Conditions

Mycophenolate Mofetil
Cyclophosphamide
Lupus Nephritis

Interventions

DRUG: Cyclophosphamide
DRUG: Mycophenolate Mofetil

Sponsor

Second Xiangya Hospital of Central South University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]